299 related articles for article (PubMed ID: 8589255)
1. Development of a model for the delta-opioid receptor pharmacophore: 3. Comparison of the cyclic tetrapeptide, Tyr-c[D-Cys-Phe-D-Pen]OH with other conformationally constrained delta-receptor selective ligands.
Lomize AL; Pogozheva ID; Mosberg HI
Biopolymers; 1996 Feb; 38(2):221-34. PubMed ID: 8589255
[TBL] [Abstract][Full Text] [Related]
2. Development of a model for the delta opioid receptor pharmacophore. 1. Conformationally restricted Tyr1 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
Mosberg HI; Lomize AL; Wang C; Kroona H; Heyl DL; Sobczyk-Kojiro K; Ma W; Mousigian C; Porreca F
J Med Chem; 1994 Dec; 37(25):4371-83. PubMed ID: 7996549
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of various proposed models of the receptor-bound conformation of H-Tyr-Tic-Phe-OH related delta-opioid antagonists.
Wilkes BC; Schiller PW
Biopolymers; 1995; 37(6):391-400. PubMed ID: 8589244
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cyclic delta-opioid peptides with non-peptide delta-agonist spiroindanyloxymorphone (SIOM) using the message-address concept: a molecular modeling study.
Gao P
J Comput Aided Mol Des; 1996 Aug; 10(4):327-36. PubMed ID: 8877704
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the bioactive form of linear peptide antagonists at the omega-opioid receptor.
Chao TM; Perez JJ; Loew GH
Biopolymers; 1996 Jun; 38(6):759-68. PubMed ID: 8652796
[TBL] [Abstract][Full Text] [Related]
6. Development of a model for the delta opioid receptor pharmacophore. 2. Conformationally restricted Phe3 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
Mosberg HI; Omnaas JR; Lomize A; Heyl DL; Nordan I; Mousigian C; Davis P; Porreca F
J Med Chem; 1994 Dec; 37(25):4384-91. PubMed ID: 7996550
[TBL] [Abstract][Full Text] [Related]
7. Development of a model for the delta-opioid receptor pharmacophore. 4. Residue 3 dehydrophenylalanine analogues of Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13) confirm required gauche orientation of aromatic side chain.
Mosberg HI; Dua RK; Pogozheva ID; Lomize AL
Biopolymers; 1996 Sep; 39(3):287-96. PubMed ID: 8756510
[TBL] [Abstract][Full Text] [Related]
8. A three-dimensional model of the delta-opioid pharmacophore: comparative molecular modeling of peptide and nonpeptide ligands.
Shenderovich MD; Liao S; Qian X; Hruby VJ
Biopolymers; 2000 Jun; 53(7):565-80. PubMed ID: 10766952
[TBL] [Abstract][Full Text] [Related]
9. Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists.
Schiller PW; Nguyen TM; Weltrowska G; Wilkes BC; Marsden BJ; Lemieux C; Chung NN
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11871-5. PubMed ID: 1334552
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the structural parameters involved in the delta-opioid selectivity of several families of opioid peptides.
Guis C; Bruetschy L; Meudal H; Roques BP; Gacel GA
Int J Pept Protein Res; 1993 Jun; 41(6):576-86. PubMed ID: 8394291
[TBL] [Abstract][Full Text] [Related]
11. Theoretical conformational analysis of the opioid delta antagonist H-Tyr-Tic-Phe-OH and the mu agonist H-Tyr-D-Tic-Phe-NH2.
Wilkes BC; Schiller PW
Biopolymers; 1994 Sep; 34(9):1213-9. PubMed ID: 7948733
[TBL] [Abstract][Full Text] [Related]
12. Substitution of aromatic and nonaromatic amino acids for the Phe3 residue in the delta-selective opioid peptide deltorphin I: effects on binding affinity and selectivity.
Heyl DL; Schmitter SJ; Bouzit H; Johnson TW; Hepp AM; Kurtz KR; Mousigian C
Int J Pept Protein Res; 1994 Nov; 44(5):420-6. PubMed ID: 7896499
[TBL] [Abstract][Full Text] [Related]
13. Topographical requirements for delta-selective opioid peptides.
Nikiforovich GV; Hruby VJ; Prakash O; Gehrig CA
Biopolymers; 1991 Jul; 31(8):941-55. PubMed ID: 1782355
[TBL] [Abstract][Full Text] [Related]
14. Modification of the Phe3 aromatic moiety in delta receptor-selective dermorphin/deltorphin-related tetrapeptides. Effects on opioid receptor binding.
Heyl DL; Mosberg HI
Int J Pept Protein Res; 1992 May; 39(5):450-7. PubMed ID: 1330964
[TBL] [Abstract][Full Text] [Related]
15. The receptor-bound conformation of H-Tyr-Tic-(Phe-Phe)-OH-related delta-opioid antagonists contains all trans peptide bonds.
Wilkes BC; Nguyen TM; Weltrowska G; Carpenter KA; Lemieux C; Chung NN; Schiller PW
J Pept Res; 1998 May; 51(5):386-94. PubMed ID: 9606018
[TBL] [Abstract][Full Text] [Related]
16. Modifications of the cyclic mu receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]NH2 (Et): effects on opioid receptor binding and activation.
McFadyen IJ; Ho JC; Mosberg HI; Traynor JR
J Pept Res; 2000 Mar; 55(3):255-61. PubMed ID: 10727108
[TBL] [Abstract][Full Text] [Related]
17. N-methylated cyclic enkephalin analogues retain high opioid receptor binding affinity.
Weltrowska G; Berezowska I; Lemieux C; Chung NN; Wilkes BC; Schiller PW
Chem Biol Drug Des; 2010 Feb; 75(2):182-8. PubMed ID: 20028398
[TBL] [Abstract][Full Text] [Related]
18. Comparison of conformational properties of linear and cyclic delta selective opioid ligands DTLET (Tyr-D X Thr-Gly-Phe-Leu-Thr) and DPLPE (Tyr-c[D X Pen-Gly-Phe-Pen]) by 1H n.m.r. spectroscopy.
Belleney J; Roques BP; Fournie-Zaluski MC
Int J Pept Protein Res; 1987 Sep; 30(3):356-64. PubMed ID: 3692682
[TBL] [Abstract][Full Text] [Related]
19. Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints.
Pogozheva ID; Lomize AL; Mosberg HI
Biophys J; 1998 Aug; 75(2):612-34. PubMed ID: 9675164
[TBL] [Abstract][Full Text] [Related]
20. The TIPP opioid peptide family: development of delta antagonists, delta agonists, and mixed mu agonist/delta antagonists.
Schiller PW; Weltrowska G; Berezowska I; Nguyen TM; Wilkes BC; Lemieux C; Chung NN
Biopolymers; 1999; 51(6):411-25. PubMed ID: 10797230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
